Spyre Therapeutics Announces Grants of Inducement Awards
Spyre Therapeutics, Inc. a clinical-stage biotechnology company utilizing best-in-class antibody engineering, dose optimization and rational therapeutic combinations to target improved efficacy and convenience in the treatment of IBD and other immune-mediated diseases, today announced that Spyre’s independent Compensation Committee of…